Table 1. Clinical characteristics of study participants by gender.
Male | Female | P‐value* | Total | |
---|---|---|---|---|
n | 52,360 (60.2%) | 34,924 (39.8%) | 87,284 | |
Age (years) | 42.1 ± 8.1 | 42.2 ± 9.0 | 0.8 | 42.1 ± 8.5 |
Fasting glucose (mg/dL) | 95.4 ± 8.9 | 92.1 ± 8.1 | <0.001 | 94.1 ± 8.7 |
HbA1c (%) | 5.55 ± 0.26 | 5.54 ± 0.27 | <0.001 | 5.55 ± 0.27 |
Hb (g/dL) | 15.5 ± 0.8 | 13.2 ± 0.8 | <0.001 | 14.5 ± 1.37 |
Body mass index (kg/m2) | 24.4 ± 2.8 | 22.2 ± 3.0 | <0.001 | 23.4 ± 3.1 |
Systolic BP (mmHg) | 116.1 ± 11.4 | 111.0 ± 12.6 | <0.001 | 114.0 ± 12.1 |
LDL‐C (mg/dL) | 118.6 ± 27.4 | 106.8 ± 29.0 | <0.001 | 113.9 ± 29.7 |
HDL‐C (mg/dL) | 51.8 ± 11.0 | 61.8 ± 13.5 | <0.001 | 55.8 ± 13.0 |
Triglyceride (mg/dL) | 146.6 ± 91.3 | 94.2 ± 54.2 | <0.001 | 125.3 ± 82.2 |
Total cholesterol (mg/dL) | 199.3 ± 33.0 | 191.5 ± 33.1 | <0.001 | 196.1 ± 33.2 |
Data are n (%) or means ± standard deviation. *Estimated by unpaired t‐test. BP, blood pressure; Hb, hemoglobin; HbA1c, hemoglobin A1c; HDL‐C, high‐density lipoprotein cholesterol; HOMA‐IR, homeostasis model assessment of insulin resistance; LDL, low density lipoprotein‐cholesterol.